$DTIL Q3 '26 Earnings Results & Recap Precision BioSciences reported Q3 2026 revenue of $0, total operating expenses of $20.43M, operating loss of $20.43M, and net loss of $7.59M, versus $21.77M net loss in Q3 2025.
$DTIL Q3 '26 Earnings Results & Recap Precision BioSciences reported Q3 2026 revenue of $0, total operating expenses of $20.43M, operating loss of $20.43M, and net loss of $7.59M, versus $21.77M net loss in Q3 2025.